AssetMark Inc’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
ACM
SBCM
AssetMark Inc's SOPH Position: Q3 2026 in Review
AssetMark Inc increased its SOPHiA GENETICS (SOPH) stake by 23% in Q3 2026, buying an estimated $14.8K and bringing the position to 10,897 shares worth $91.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1679.
AssetMark Inc first reported a position in SOPH in Q1 2022 and has held it in 19 quarters since. 23 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.
- AssetMark Inc held 10,897 shares of SOPHiA GENETICS worth $91.3K as of Q3 2026.
- AssetMark Inc bought 2,061 SOPHiA GENETICS shares in Q3 2026, an estimated $14.8K.
- SOPHiA GENETICS made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1679 holding.
- AssetMark Inc first reported a position in SOPHiA GENETICS in Q1 2022 and has held it in 19 quarters since.
- 23 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.
Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.